Graft Versus Host Disease (GVHD)

Health-Related Quality of Life, AAMDSIF 2026 International Bone Marrow Failure Scientific Symposium

Thumbnail for video Watch Now

Presenter(s)
Namrata Chandhok, MD
Thomas LeBlanc, MD, MA
Fabio Efficace, PhD
Alison R. Kavanaugh
Pamela C. Egan, MD
Wil L. Santivasi, MD
The session was recorded at the AAMDSIF 2026 International Bone Marrow Failure Scientific Symposium, Co-Chairs Namrata Chandhok, MD, and Thomas LeBlanc, MD, MA Topics and speakers included: How can we measure quality of life in MDS, to inform interventions? - Fabio Efficace, PhD…

Non-Transplant Therapies for Marrow Failure, AAMDSIF 2026 International Bone Marrow Failure Scientific Symposium

Thumbnail for video Watch Now

Presenter(s)
Carlos DeCastro, MD
Phil Scheinberg, MD
Regis Peffault de Latour, MD, PhD
Julian Sevilla, MD, PhD
Kasiani Myers, MD
Suneet Agarwal, MD, PhD
This session was presented at the AAMDSIF 2026 International Bone Marrow Failure Scientific Symposium; Co-Chairs Carlos DeCastro, MD, and Phil Scheinberg, MD, PhD. Session topics included: -Androgens, alemtuzumab, anti-cytokine therapies (anti-IL2R, anti-IFN gamma), daratumumab…

How I select hematopoietic cell donors in the era of posttransplant cyclophosphamide

Original Publication Date
Article Source
External Web Content

Abstract Selection of a hematopoietic progenitor cell donor for allogeneic hematopoietic cell transplantation (HCT) is essential for treatment planning; however, the parameters that define an “optimal” donor in the modern era are not well defined. Historically, donor-recipient…

Impact of Modern Strategies for Graft-Versus-Host Disease Prophylaxis on Relapse Risk in Matched-Sibling or Unrelated Donor Hematopoietic Cell Transplantation: A Systematic Review and Meta-Analysis of Randomized Trials

Original Publication Date
Article Source
External Web Content

ABSTRACT Regimens combining calcineurin inhibitors with methotrexate or mycophenolate have been the backbone for graft-versus-host disease (GVHD) prophylaxis. Early studies highlighted a delicate dose–response balance. The inclusion criteria comprised randomized clinical trials…

Gastrin for the treatment of acute graft-versus-host disease of the stomach

Original Publication Date
Article Source
External Web Content

Key Points aGVHD causes loss of gastric stem cells, G-cells, and PCs, leading to increased gastric pH. Pentagastrin therapy repairs stem cell and PC deficits, reverses pH changes, and reduces aGVHD damage, improving survival. Abstract Acute graft-versus-host disease (aGVHD) is a…

Satyajit Kosuri, MD

Institution
Duchossois Center for Advanced Medicine - Hyde Park
Physician Status
accepting new patients
Primary Disease Area of Focus
Acute Myeloid Leukemia (AML)
Graft Versus Host Disease (GVHD)
Myelodysplastic Syndromes (MDS)
About

Satyajit Kosuri, MD, is a medical oncologist who treats adult patients with acute leukemia, myelodysplastic syndrome and myelofibrosis. He is an expert in stem cell transplantation (also known as bone marrow transplant) and leads the Graft-Versus-Host Disease (GVHD) Clinic, a program designed to prevent and treat GVHD, a complication of allogeneic stem cell transplant. His clinical research focuses on improving patient access to transplant through the use of alternative donor strategies and the use of novel immune therapies in these diseases. His main passion is guiding his patients through

Subscribe to Graft Versus Host Disease (GVHD)

Website Feedback

Please use this feedback form to report website issues only. For other issues concerning patients and families, please email help@aamds.org or use the Patient and Family Helpline here.